Table of Content

Chapter 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits to the Stakeholders
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
Chapter 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
Chapter 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Impacting Factors
3.2.2. Top Investment Pockets
3.3. Porter’s Five Forces Analysis
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
Chapter 4: JAPAN RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE
4.1. Overview
4.1.1. Market Size and Forecast, By Radioisotope
4.2. Technetium 99m
4.3. Fluorine 18
4.4. Iodine I
4.5. Gallium 68
4.6. Others
Chapter 5: JAPAN RADIOPHARMACEUTICALS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market Size and Forecast, By Application
5.2. Cancer
5.3. Cardiology
5.4. Others
Chapter 6: JAPAN RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Overview
6.1.1. Market Size and Forecast, By Type
6.2. Diagnostic
6.3. Therapeutic
Chapter 7: JAPAN RADIOPHARMACEUTICALS MARKET, BY END USER
7.1. Overview
7.1.1. Market Size and Forecast, By End User
7.2. Hospitals and clinics
7.3. Medical Imaging centers
7.4. Others
Chapter 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
Chapter 9: COMPANY PROFILES
9.1. Daiichi Sankyo Co., Ltd.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Sumitomo Dainippon Pharma Co., Ltd.
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Fujifilm RI Pharma Co., Ltd.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Takeda Pharmaceutical Company Limited
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Yakult Honsha Co., Ltd.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Astellas Pharma Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. Eisai Co., Ltd.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.7.7. Key strategic moves and developments
9.8. Kyowa Hakko Kirin Co., Ltd.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. Japan Radioisotope Association
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.9.7. Key strategic moves and developments
9.10. Japan Pharmaceutical Manufacturers Association
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments



List of Figures

LIST OF FIGURES
FIGURE 01. JAPAN RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF JAPAN RADIOPHARMACEUTICALS MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN JAPAN RADIOPHARMACEUTICALS MARKET (2023-2032)
FIGURE 04. PORTER FIVE-1
FIGURE 05. PORTER FIVE-2
FIGURE 06. PORTER FIVE-3
FIGURE 07. PORTER FIVE-4
FIGURE 08. PORTER FIVE-5
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: JAPAN RADIOPHARMACEUTICALS MARKET
FIGURE 10. JAPAN RADIOPHARMACEUTICALS MARKET,BY RADIOISOTOPE, 2022 ($MILLION)
FIGURE 11. JAPAN RADIOPHARMACEUTICALS MARKET,BY APPLICATION, 2022 ($MILLION)
FIGURE 12. JAPAN RADIOPHARMACEUTICALS MARKET,BY TYPE, 2022 ($MILLION)
FIGURE 13. JAPAN RADIOPHARMACEUTICALS MARKET,BY END USER, 2022 ($MILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: JAPAN RADIOPHARMACEUTICALS MARKET
FIGURE 20. TOP PLAYER POSITIONING, 2022
FIGURE 21. DAIICHI SANKYO CO., LTD.: NET SALES, 2020-2022*?($MILLION)
FIGURE 22. DAIICHI SANKYO CO., LTD.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 23. DAIICHI SANKYO CO., LTD.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 24. SUMITOMO DAINIPPON PHARMA CO., LTD.: NET SALES, 2020-2022*?($MILLION)
FIGURE 25. SUMITOMO DAINIPPON PHARMA CO., LTD.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 26. SUMITOMO DAINIPPON PHARMA CO., LTD.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 27. FUJIFILM RI PHARMA CO., LTD.: NET SALES, 2020-2022*?($MILLION)
FIGURE 28. FUJIFILM RI PHARMA CO., LTD.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 29. FUJIFILM RI PHARMA CO., LTD.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 30. TAKEDA PHARMACEUTICAL COMPANY LIMITED: NET SALES, 2020-2022*?($MILLION)
FIGURE 31. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 32. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 33. YAKULT HONSHA CO., LTD.: NET SALES, 2020-2022*?($MILLION)
FIGURE 34. YAKULT HONSHA CO., LTD.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 35. YAKULT HONSHA CO., LTD.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 36. ASTELLAS PHARMA INC.: NET SALES, 2020-2022*?($MILLION)
FIGURE 37. ASTELLAS PHARMA INC.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 38. ASTELLAS PHARMA INC.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 39. EISAI CO., LTD.: NET SALES, 2020-2022*?($MILLION)
FIGURE 40. EISAI CO., LTD.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 41. EISAI CO., LTD.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 42. KYOWA HAKKO KIRIN CO., LTD.: NET SALES, 2020-2022*?($MILLION)
FIGURE 43. KYOWA HAKKO KIRIN CO., LTD.: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 44. KYOWA HAKKO KIRIN CO., LTD.: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 45. JAPAN RADIOISOTOPE ASSOCIATION: NET SALES, 2020-2022*?($MILLION)
FIGURE 46. JAPAN RADIOISOTOPE ASSOCIATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 47. JAPAN RADIOISOTOPE ASSOCIATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)
FIGURE 48. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: NET SALES, 2020-2022*?($MILLION)
FIGURE 49. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: REVENUE SHARE, BY SEGMENT, 2022 (%)
FIGURE 50. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: REVENUE SHARE, BY GEOGRAPHY, 2022 (%)

List of Tables

LIST OF TABLES
TABLE 01. JAPAN RADIOPHARMACEUTICALS MARKET, BY RADIOISOTOPE, 2022-2032 ($MILLION)
TABLE 02. JAPAN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 03. JAPAN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 04. JAPAN RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 05. DAIICHI SANKYO CO., LTD.: KEY EXECUTIVES
TABLE 06. DAIICHI SANKYO CO., LTD.: COMPANY SNAPSHOT
TABLE 07. DAIICHI SANKYO CO., LTD.: OPERATING SEGMENTS
TABLE 08. DAIICHI SANKYO CO., LTD.: PRODUCT PORTFOLIO
TABLE 09. DAIICHI SANKYO CO., LTD.: KEY STRATERGIES
TABLE 10. SUMITOMO DAINIPPON PHARMA CO., LTD.: KEY EXECUTIVES
TABLE 11. SUMITOMO DAINIPPON PHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 12. SUMITOMO DAINIPPON PHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 13. SUMITOMO DAINIPPON PHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 14. SUMITOMO DAINIPPON PHARMA CO., LTD.: KEY STRATERGIES
TABLE 15. FUJIFILM RI PHARMA CO., LTD.: KEY EXECUTIVES
TABLE 16. FUJIFILM RI PHARMA CO., LTD.: COMPANY SNAPSHOT
TABLE 17. FUJIFILM RI PHARMA CO., LTD.: OPERATING SEGMENTS
TABLE 18. FUJIFILM RI PHARMA CO., LTD.: PRODUCT PORTFOLIO
TABLE 19. FUJIFILM RI PHARMA CO., LTD.: KEY STRATERGIES
TABLE 20. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY EXECUTIVES
TABLE 21. TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 22. TAKEDA PHARMACEUTICAL COMPANY LIMITED: OPERATING SEGMENTS
TABLE 23. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT PORTFOLIO
TABLE 24. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY STRATERGIES
TABLE 25. YAKULT HONSHA CO., LTD.: KEY EXECUTIVES
TABLE 26. YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
TABLE 27. YAKULT HONSHA CO., LTD.: OPERATING SEGMENTS
TABLE 28. YAKULT HONSHA CO., LTD.: PRODUCT PORTFOLIO
TABLE 29. YAKULT HONSHA CO., LTD.: KEY STRATERGIES
TABLE 30. ASTELLAS PHARMA INC.: KEY EXECUTIVES
TABLE 31. ASTELLAS PHARMA INC.: COMPANY SNAPSHOT
TABLE 32. ASTELLAS PHARMA INC.: OPERATING SEGMENTS
TABLE 33. ASTELLAS PHARMA INC.: PRODUCT PORTFOLIO
TABLE 34. ASTELLAS PHARMA INC.: KEY STRATERGIES
TABLE 35. EISAI CO., LTD.: KEY EXECUTIVES
TABLE 36. EISAI CO., LTD.: COMPANY SNAPSHOT
TABLE 37. EISAI CO., LTD.: OPERATING SEGMENTS
TABLE 38. EISAI CO., LTD.: PRODUCT PORTFOLIO
TABLE 39. EISAI CO., LTD.: KEY STRATERGIES
TABLE 40. KYOWA HAKKO KIRIN CO., LTD.: KEY EXECUTIVES
TABLE 41. KYOWA HAKKO KIRIN CO., LTD.: COMPANY SNAPSHOT
TABLE 42. KYOWA HAKKO KIRIN CO., LTD.: OPERATING SEGMENTS
TABLE 43. KYOWA HAKKO KIRIN CO., LTD.: PRODUCT PORTFOLIO
TABLE 44. KYOWA HAKKO KIRIN CO., LTD.: KEY STRATERGIES
TABLE 45. JAPAN RADIOISOTOPE ASSOCIATION: KEY EXECUTIVES
TABLE 46. JAPAN RADIOISOTOPE ASSOCIATION: COMPANY SNAPSHOT
TABLE 47. JAPAN RADIOISOTOPE ASSOCIATION: OPERATING SEGMENTS
TABLE 48. JAPAN RADIOISOTOPE ASSOCIATION: PRODUCT PORTFOLIO
TABLE 49. JAPAN RADIOISOTOPE ASSOCIATION: KEY STRATERGIES
TABLE 50. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: KEY EXECUTIVES
TABLE 51. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: COMPANY SNAPSHOT
TABLE 52. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: OPERATING SEGMENTS
TABLE 53. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: PRODUCT PORTFOLIO
TABLE 54. JAPAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION: KEY STRATERGIES